An Inhibitory Metabolite Leads to Dose- and Time-Dependent Pharmacokinetics of (R)-N-{1-[3-(4-Ethoxy-phenyl)-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl]-ethyl}-N-pyridin-3-yl-methyl-2-(4-trifluoromethoxy-phenyl)-acetamide (AMG 487) in Human Subjects After Multiple Dosing

MLA

Bradley K. Wong, et al. “An Inhibitory Metabolite Leads to Dose- and Time-Dependent Pharmacokinetics of (R)-N-{1-[3-(4-Ethoxy-Phenyl)-4-Oxo-3,4-Dihydro-Pyrido[2,3-d]Pyrimidin-2-Yl]-Ethyl}-N-Pyridin-3-Yl-Methyl-2-(4-Trifluoromethoxy-Phenyl)-Acetamide (AMG 487) in Human Subjects After Multiple Dosing.” Drug Metabolism and Disposition, vol. 37, Dec. 2008, pp. 502–13. EBSCOhost, https://doi.org/10.1124/dmd.108.021931.

APA

Bradley K. Wong, Bettina Van Lengerich, Sylvia C. Wong, Andrew P. Marcus, Paul G. Pearson, Xuemei Wang, Leslie C. Floren, Karen Berry, Robert Cho, George Tonn, Julio C. Medina, Simon Wong, Kathryn Kersey, Ji Ma, & Michael G. Johnson. (2008). An Inhibitory Metabolite Leads to Dose- and Time-Dependent Pharmacokinetics of (R)-N-{1-[3-(4-Ethoxy-phenyl)-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl]-ethyl}-N-pyridin-3-yl-methyl-2-(4-trifluoromethoxy-phenyl)-acetamide (AMG 487) in Human Subjects After Multiple Dosing. Drug Metabolism and Disposition, 37, 502–513. https://doi.org/10.1124/dmd.108.021931

Chicago

Bradley K. Wong, Bettina Van Lengerich, Sylvia C. Wong, Andrew P. Marcus, Paul G. Pearson, Xuemei Wang, Leslie C. Floren, et al. 2008. “An Inhibitory Metabolite Leads to Dose- and Time-Dependent Pharmacokinetics of (R)-N-{1-[3-(4-Ethoxy-Phenyl)-4-Oxo-3,4-Dihydro-Pyrido[2,3-d]Pyrimidin-2-Yl]-Ethyl}-N-Pyridin-3-Yl-Methyl-2-(4-Trifluoromethoxy-Phenyl)-Acetamide (AMG 487) in Human Subjects After Multiple Dosing.” Drug Metabolism and Disposition 37 (December): 502–13. doi:10.1124/dmd.108.021931.